Conference Coverage

Xenon imaging could detect lung involvement after HSCT


 

REPORTING FROM THE 2018 BMT TANDEM MEETINGS


Drops in blood oxygen saturation level did occur, but were transient and resolved within 10-30 seconds of normal breathing. Further, there were no changes in heart rate during imaging, and any side effects related to xenon, such as tingling in extremities, dizziness, or euphoria, were also quickly resolved with normal breathing, she said.

“There were no serious adverse events related to the study ... these results are in good agreement with previously published safety assessments of xenon in kids and in adults, and at our institution we routinely perform xenon imaging in children as young as age 6,” she added.

The findings, which are consistent with those seen in studies of other conditions such as cystic fibrosis, asthma, and chronic obstructive pulmonary disease, suggest that 129Xe MRI is an emerging modality with strong translational potential for detecting early pulmonary involvement following HSCT, she said.

“The real power of the xenon MRI is the spatial information that it provides; we can use that information to plan targeted procedures like bronchoscopy and biopsies ... and since it is non-ionizing, it may be used serially to assess disease progression or response to an intervention,” Dr. Walkup said.

Pages

Recommended Reading

A mismatched haplotype may improve outcomes in second BMT
MDedge Hematology and Oncology
Checkpoint inhibitors look safe in rheumatology patients
MDedge Hematology and Oncology
Tisagenlecleucel looks effective in phase 2 study of young ALL patients
MDedge Hematology and Oncology
HCT-CI score may predict mortality for nonmalignant disease
MDedge Hematology and Oncology
High efficacy, no safety signals for herpes zoster vaccine post-HSCT
MDedge Hematology and Oncology
Cancer groups offer guidance on immune-related adverse events
MDedge Hematology and Oncology
Outpatient CAR T infusions feasible using liso-cel
MDedge Hematology and Oncology
Nonmyeloablative conditioning gets a radiation boost for severe hemoglobinopathies
MDedge Hematology and Oncology
KD025 shows promise for steroid-dependent cGVHD
MDedge Hematology and Oncology
CAR T before transplant yields durable remission in B-cell malignancies
MDedge Hematology and Oncology